Kopran Limited

Kopran Limited (KOPRAN) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

kopran.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹232.24
Market cap
1,120 Cr
Stock P/E
25.3
P/B
2.11
Dividend yield
1.3%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales153 Cr159 Cr186 Cr139 Cr152 Cr166 Cr172 Cr135 Cr118 Cr194 Cr234 Cr154 Cr
Operating expenses (approx.)130 Cr135 Cr164 Cr121 Cr137 Cr146 Cr155 Cr121 Cr123 Cr177 Cr201 Cr138 Cr
EBITDA23 Cr24 Cr22 Cr18 Cr15 Cr20 Cr17 Cr14 Cr-5 Cr18 Cr33 Cr16 Cr
OPM %15.0%14.8%11.7%13.0%9.7%11.9%9.9%10.5%-4.5%9.1%14.1%10.3%
Other income0.13 Cr2 Cr10 Cr3 Cr0.99 Cr0.17 Cr3 Cr3 Cr0.03 Cr0.07 Cr0.09 Cr2 Cr
Interest2 Cr2 Cr3 Cr2 Cr2 Cr2 Cr3 Cr3 Cr2 Cr3 Cr3 Cr3 Cr
Depreciation3 Cr3 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr5 Cr6 Cr
Profit before tax18 Cr21 Cr25 Cr15 Cr10 Cr14 Cr14 Cr10 Cr-12 Cr11 Cr25 Cr9 Cr
Tax %24.6%23.0%26.0%24.7%23.4%25.0%29.4%24.7%14.6%13.1%25.6%23.9%
Net profit14 Cr16 Cr19 Cr11 Cr7 Cr10 Cr10 Cr7 Cr-10 Cr9 Cr19 Cr7 Cr
EPS (₹)₹2.86₹3.28₹3.86₹2.30₹1.53₹0.00₹2.01₹1.54₹-2.06₹1.93₹3.91₹1.39

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales358 Cr359 Cr492 Cr478 Cr551 Cr615 Cr630 Cr681 CrSign in for TTM
Operating expenses (approx.)312 Cr313 Cr410 Cr390 Cr499 Cr540 Cr557 Cr619 CrSign in for TTM
EBITDA46 Cr47 Cr82 Cr87 Cr52 Cr74 Cr73 Cr62 CrSign in for TTM
OPM %12.9%13.0%16.6%18.3%9.4%12.1%11.6%9.1%Sign in for TTM
Other income3 Cr0.63 Cr18 Cr11 Cr3 Cr15 Cr4 Cr0.35 CrSign in for TTM
Interest9 Cr9 Cr6 Cr5 Cr6 Cr9 Cr9 Cr10 CrSign in for TTM
Depreciation9 Cr10 Cr10 Cr11 Cr13 Cr13 Cr16 Cr17 CrSign in for TTM
Profit before tax32 Cr28 Cr83 Cr82 Cr36 Cr68 Cr52 Cr34 CrSign in for TTM
Tax %24.1%25.7%26.1%25.4%24.5%24.6%25.8%25.1%Sign in for TTM
Net profit24 Cr21 Cr62 Cr61 Cr27 Cr51 Cr39 Cr26 CrSign in for TTM
EPS (₹)₹5.55₹4.86₹14.24₹13.77₹5.65₹10.57₹7.99₹5.33Sign in for TTM
Dividend payout %———10.6%53.1%28.4%0.0%56.3%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital43 Cr43 Cr43 Cr48 Cr48 Cr48 Cr48 Cr48 Cr
Reserves125 Cr146 Cr202 Cr378 Cr391 Cr443 Cr470 Cr482 Cr
Borrowings87 Cr78 Cr64 Cr72 Cr75 Cr99 Cr148 Cr153 Cr
Other liabilities97 Cr104 Cr130 Cr112 Cr135 Cr153 Cr178 Cr225 Cr
Total liabilities352 Cr371 Cr439 Cr611 Cr650 Cr743 Cr844 Cr908 Cr
Fixed assets (net)112 Cr111 Cr109 Cr148 Cr163 Cr179 Cr197 Cr337 Cr
CWIP17 Cr22 Cr37 Cr28 Cr56 Cr78 Cr99 Cr2 Cr
Investments2 Cr0.02 Cr0.05 Cr4 Cr0.06 Cr0.06 Cr0.06 Cr0.06 Cr
Loans & advances4 Cr0.87 Cr0.47 Cr0.62 Cr0.74 Cr1 Cr8 Cr8 Cr
Inventories73 Cr88 Cr100 Cr150 Cr131 Cr138 Cr169 Cr164 Cr
Trade receivables87 Cr93 Cr120 Cr127 Cr163 Cr212 Cr215 Cr263 Cr
Cash & bank0.41 Cr0.83 Cr0.94 Cr6 Cr7 Cr8 Cr19 Cr0.68 Cr
Other assets56 Cr56 Cr71 Cr148 Cr130 Cr127 Cr136 Cr133 Cr
Total assets352 Cr371 Cr439 Cr611 Cr650 Cr743 Cr844 Cr908 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———-34 Cr34 Cr43 Cr42 Cr67 Cr
Cash from investing———-84 Cr-13 Cr-44 Cr-56 Cr-65 Cr
Cash from financing———123 Cr-20 Cr0.99 Cr26 Cr-21 Cr
Net cash flow———5 Cr2 Cr0.69 Cr11 Cr-19 Cr
Free cash flow (OCF − Capex)———-76 Cr-27 Cr-13 Cr-17 Cr-0.37 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %15.9%19.6%36.6%17.4%8.2%12.9%9.2%6.6%
ROE %16.0%11.1%25.1%22.7%6.2%0.0%7.4%0.0%
Debtor days88948997107126124140
Inventory days136145137184148128154139
Days payable95901187699105108133
Cash conversion cycle129149108204156150170146
Debt / equity0.000.410.260.170.170.200.290.29
Current ratio1.541.591.722.742.252.082.021.51
Net debt / EBITDA0.000.000.000.001.311.221.762.45

Compare with peers

Loading peers…